5442
0
09.07.2020 Novavax Daily Analysis
NVAX was in the news this week as it received $1.6 billion from Operation Warp Speed to complete late-stage clinical development, establish large-scale
Yazar: editor_1
Yayınlanma: 9 Temmuz 2020 21:07
Güncellenme: 13 Aralık 2024 01:47
09.07.2020 Novavax Daily Analysis
NVAX was in the news this week as it received $1.6 billion from Operation Warp Speed to complete late-stage clinical development, establish large-scale manufacturing, and deliver 100 million doses of NVX‑CoV2373, Novavax’ COVID-19 vaccine candidate, as early as late 2020. It’s the largest contribution from Operation Warp Speed thus far, and many consider NVAX to be one of the leaders. The company’s vaccine aims to increase the body’s production of antibodies to block the protein that the coronavirus uses to invade cells. NVAX is expected to report the results of its phase 2 trial later this month and begin a final-stage study with 30,000 participants this fall.İLGİLİ HABERLER
European stocks soared and focus shifted to German retail sales after Powell's speech!
Forex Signal For TRY/USD: Inflation Slowdown in November.
Forex Signal For GBP/USD: Bullish Trend Still Not Breaking While Recovery Continues.
Forex Signal For EUR/USD: Starry US Data Points to Higher Fed Increases.
Forex Signal For BTC/USD: Downside Continues as Bitcoin Recovery Moves Less.
En Popüler Haberler
Yorum Yap
Yorumlar
Henüz yorum yapan yok! İlk yorumu siz yapın...